Company / Working Capital
Nuvation Bio Inc. Working Capital History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$489.3M
FY2025
5-year range
$468.0M / $755.1M
FY2021-FY2025
Trend
+4.5%
vs FY2024
Sector context
#95 of 213
Health Care
What the data says
At $489M, Nuvation Bio Inc.'s working capital ranks #95 of 213 in the Health Care sector. Working Capital returned to growth in FY2025 after 3 years of decline, reaching $489M.
Based on SEC 10-K filings.
$489M in FY2025 with a 5-year CAGR of +18.0%.
Declined from $602M to $489M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -9.2%
- 5-Year CAGR
- +18.0%
- 10-Year CAGR
- -
Sector benchmark
#95 of 213 in Health CareTop 45% of 213This company $489.3M Sector average $934.6M
▼
-47.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +18.0%, indicating consistent growth.
- In FY2025, working capital increased 4.5% year-over-year.
- Ranks #95 out of 213 companies in the Health Care sector.
- Peak working capital was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -1.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $489.3M | +4.5% |
| FY2024 | $468.0M | -22.3% |
| FY2023 | $602.5M | -7.9% |
| FY2022 | $654.2M | -13.4% |
| FY2021 | $755.1M | +252.7% |
| FY2020 | $214.1M | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026